Search research articles
Contact Us
Filters
Showing results (151-160 of 877) with videos related to
Page
of 88
Sort By:
Immunology
|
August 2, 2006
During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment
Malcolm S Duthie, Stuart J Kahn
The Journal of Rheumatology
|
May 3, 2013
Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome
Philip J Kahn, Randy Q Cron
Rambam Maimonides Medical Journal
|
October 13, 2018
Crises and Turnaround Management: Lessons Learned from Recovery of New Orleans and Tulane University Following Hurricane Katrina
Marc J Kahn, Benjamin P Sachs
Journal of Health Care Finance
|
November 20, 2012
A real options approach to clinical faculty salary structure
Marc J Kahn, Hugh W Long
AMA Journal of Ethics
|
February 14, 2015
Promoting the affordability of medical education to groups underrepresented in the profession: the other side of the equation
Marc J Kahn, Ernest J Sneed
Hematology/Oncology Clinics of North America
|
August 1, 1997
Chemoprevention for colorectal carcinoma
M J Kahn, D G Morrison
Pediatric Pathology
|
January 1, 1989
Monoclonal antibody MB2: a potential marker for Ewing's sarcoma and primitive neuroectodermal tumor
H J Kahn, P S Thorner
Semaine Des Hopitaux. Therapeutique
|
April 1, 1975
[Surgical treatment of acute cholecystitis]
M Gillet, G Camelot, J Kahn
The New England Journal of Medicine
|
December 20, 1997
The Medical Repository--the first U.S. medical journal (1797-1824)
R J Kahn, P G Kahn
Academic Medicine : Journal of the Association of American Medical Colleges
|
February 17, 2000
Using standardized patients to teach end-of-life skills to clinical clerks
M J Kahn, H M Szerlip
Page
of 88
Search research articles
Search
Showing results (151-160 of 877) with videos related to
Sort By:
Page
of 88
Immunology
|
August 2, 2006
During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment
Malcolm S Duthie, Stuart J Kahn
The Journal of Rheumatology
|
May 3, 2013
Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome
Philip J Kahn, Randy Q Cron
Rambam Maimonides Medical Journal
|
October 13, 2018
Crises and Turnaround Management: Lessons Learned from Recovery of New Orleans and Tulane University Following Hurricane Katrina
Marc J Kahn, Benjamin P Sachs
Journal of Health Care Finance
|
November 20, 2012
A real options approach to clinical faculty salary structure
Marc J Kahn, Hugh W Long
AMA Journal of Ethics
|
February 14, 2015
Promoting the affordability of medical education to groups underrepresented in the profession: the other side of the equation
Marc J Kahn, Ernest J Sneed
Hematology/Oncology Clinics of North America
|
August 1, 1997
Chemoprevention for colorectal carcinoma
M J Kahn, D G Morrison
Pediatric Pathology
|
January 1, 1989
Monoclonal antibody MB2: a potential marker for Ewing's sarcoma and primitive neuroectodermal tumor
H J Kahn, P S Thorner
Semaine Des Hopitaux. Therapeutique
|
April 1, 1975
[Surgical treatment of acute cholecystitis]
M Gillet, G Camelot, J Kahn
The New England Journal of Medicine
|
December 20, 1997
The Medical Repository--the first U.S. medical journal (1797-1824)
R J Kahn, P G Kahn
Academic Medicine : Journal of the Association of American Medical Colleges
|
February 17, 2000
Using standardized patients to teach end-of-life skills to clinical clerks
M J Kahn, H M Szerlip
Page
of 88